Key messages

• September 23: ADHD and Autism FAQ
• 29/06/2023: Update to the Community Access to Neutralising Monoclonal Antibodies (nMAB) and Oral Antivirals for Covid-19 Treatment
• Teledermatology for Advice & Guidance and Referrals
• Waiting Times for Routine Care
• Diabetic Eye Screening Programme (DESP)
• Hydroxychloroquine Retinopathy Monitoring
• Expediting Referrals – how to communicate with Secondary Care
• UHP Pre-choice Triage/Advice & Guidance
• Torbay and South Devon Pre-choice Triage/Advice & Guidance
• Devon patient choice statement

Referral updates

• 04/08/23 New Bleeding on HRT Clinical Referral Guideline - South Devon and Torbay locality
• 04/08/23 New Bleeding on HRT Clinical Referral Guideline - Western locality
• 04/08/23 Update to the Hypertension Clinical Referral Guideline - South Devon and Torbay locality
• 04/08/23 Update to the Hypertension Clinical Referral Guideline - Western locality
• 29/06/2023: Update to the Community Access to Neutralising Monoclonal Antibodies (nMAB) and Oral Antivirals for Covid-19 Treatment
• 26/06/2023: Update to the Actinic Keratosis Clinical Referral Guideline - Torbay and South Devon locality
• 26/06/2023: Update to the Actinic Keratosis Clinical Referral Guideline - Western locality
• 30/05/2023: Update to the Heart Failure - Suspected Heart Failure For Patients With NTproBNP greater than 2000 Torbay & South Devon locality
• 30/05/2023: Update to the Heart Failure - Heart Failure - Suspected Heart Failure Pathway For Patients With NTproBNP lower than 2000 Or An Existing Heart Failure Diagnosis Torbay & South Devon locality
• 30/05/2023: Update to the Heart Failure - Suspected Heart Failure For Patients With NTproBNP greater than 2000 Western locality locality
• 30/05/2023: Update to the Heart Failure - Heart Failure - Suspected Heart Failure Pathway For Patients With NTproBNP lower than 2000 Or An Existing Heart Failure Diagnosis Western locality

Referral feedback

• To contact the Clinical Referral Guideline Support Team